Jed Martin, in Hurtsboro, AL - Pharmacist

Jed Martin, is a Pharmacist based in Hurtsboro, Alabama. Jed Martin is licensed to practice in Alabama (license number 14368) and his current practice location is 510 Main St, Hurtsboro, Alabama. He can be reached at his office (for appointments etc.) via phone at (334) 703-7049.

NPI number for Jed Martin is 1013586221 and his current mailing address is 2413 Crawford Rd, Phenix City, Alabama. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1013586221.

Contact Information

	Jed Martin,
	510 Main St, Hurtsboro, AL 36860
	(334) 703-7049
	Not Available

Healthcare Provider's Profile

Full Name	Jed Martin
Gender	Male
Speciality	Pharmacist
Location	510 Main St, Hurtsboro, Alabama
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1013586221
Provider Enumeration Date: 06/22/2021
Last Update Date: 06/22/2021

Medical Identifiers

Medical identifiers for Jed Martin such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013586221	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	14368 (Alabama)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jed Martin is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jed Martin, 2413 Crawford Rd, Phenix City, AL 36867-3648 Ph: (334) 298-2577	Jed Martin, 510 Main St, Hurtsboro, AL 36860 Ph: (334) 703-7049

News Archive

HMS launches Initiative in Systems Pharmacology

Taking aim at the alarming slowdown in the development of new and lifesaving drugs, Harvard Medical School is launching an Initiative in Systems Pharmacology, a comprehensive strategy to transform drug discovery by convening biologists, chemists, pharmacologists, physicists, computer scientists and clinicians to explore together how drugs work in complex systems.

Guerbet receives FDA Orphan Drug Designation for Lipiodol Injection

Guerbet LLC, USA - Guerbet, a pioneer in the field of contrast agents with more than 80 years of experience, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) for Lipiodol (Ethiodized Oil) Injection for management of patients with known hepatocellular carcinoma (HCC).

DTT releases ditto dental electronic device

Diversionary Therapy Technologies (DTT) is pleased to announce the release of ditto dental, an interactive electronic device containing augmented reality content to prepare children for dental procedures, resulting in reduced stress and anxiety for the pediatric patient and increased clinical productivity.

Use of positron emission tomography may eliminate more strenuous drug development trials with animals

A number of articles explore the use of positron emission tomography (PET) and small animal imaging—nonsurgical techniques that open the door to understanding and treating human diseases—in the April issue of the Society of Nuclear Medicine's Journal of Nuclear Medicine.

CSI Laboratories to expand new diagnostic laboratory in Alpharetta

CSI Laboratories, a private national cancer diagnostic laboratory, today announced the lease of a new 65,000 square foot facility in Alpharetta, GA, located north of the city of Atlanta.

Jed Martin, - Pharmacist in Hurtsboro, AL